Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-24

Clinical Trial Update: A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.

View source ↗

Summary

Clinical trial update assessing the efficacy of etanercept over 12 months in routine treatment of rheumatoid arthritis and related inflammatory diseases; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etanercept (etanercept)

Snippet

Sponsor: Pfizer | Conditions: Rheumatoid Arthritis, Psoriatic Arthritis | Status: COMPLETED | Results posted: 2019-06-24